Pharmbio Korea Co., Ltd.
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Private
- Established
- 1999-05-01
- Employees
- 101
- Market Cap
- -
- Website
- http://www.pharmbio.co.kr
Study to Evaluate the Efficacy and Safety of PBK_L2201 in Postmenopausal Women With Osteoporosis
- First Posted Date
- 2023-12-04
- Last Posted Date
- 2023-12-04
- Lead Sponsor
- Pharmbio Korea Co., Ltd.
- Target Recruit Count
- 60
- Registration Number
- NCT06154187
- Locations
- 🇰🇷
The Catholic University of Korea Yeouido Saint Mary's Hospital, Seoul, Korea, Republic of
A Study to Evaluate Safety and Efficacy of PBK_M2101
Phase 3
Recruiting
- Conditions
- Intestinal DiseaseDigestive System DiseaseColonic DiseasesGastrointestinal Disease
- Interventions
- First Posted Date
- 2023-06-28
- Last Posted Date
- 2023-06-28
- Lead Sponsor
- Pharmbio Korea Co., Ltd.
- Target Recruit Count
- 246
- Registration Number
- NCT05923918
- Locations
- 🇰🇷
Seoul Asan Medical Center, Seoul, Korea, Republic of
Study of PBK_L1704 for the Treatment of Moderate to Severe Acute Pain After Bunionectomy in South Korea
Phase 3
- Conditions
- Acute Pain
- Interventions
- Drug: PBK_L1704 0.5mgDrug: PBK_L1704 0.35mgDrug: Placebo
- First Posted Date
- 2022-08-22
- Last Posted Date
- 2022-08-22
- Lead Sponsor
- Pharmbio Korea Co., Ltd.
- Target Recruit Count
- 225
- Registration Number
- NCT05509868
- Locations
- 🇰🇷
Seoul Asan medical Center, Seoul, Korea, Republic of
Comparison for Efficacy and Safety of Bowel Preparation Between Oral Sulfate Table and 2L-polyethylene Glycol/Ascorbate in Elderly
Phase 4
- Conditions
- Intestinal DiseaseColonic Disease
- Interventions
- Drug: OSTDrug: 2L-PEG/Asc
- First Posted Date
- 2022-02-21
- Last Posted Date
- 2022-02-21
- Lead Sponsor
- Pharmbio Korea Co., Ltd.
- Target Recruit Count
- 256
- Registration Number
- NCT05249335
Pharmacokinetics and Safety of PBK-1801 After Single Oral Administration in Healthy Korean Women
- First Posted Date
- 2020-06-05
- Last Posted Date
- 2020-06-05
- Lead Sponsor
- Pharmbio Korea Co., Ltd.
- Target Recruit Count
- 36
- Registration Number
- NCT04418388
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
Safety and Efficacy of PBK-1701TC for Bowel Cleansing Before Colonoscopy
Phase 3
Completed
- Conditions
- Colonic DiseasesIntestinal DiseaseDigestive System DiseaseGastrointestinal Disease
- Interventions
- Drug: PBK-1701TCDrug: Standard oral preparation
- First Posted Date
- 2018-04-26
- Last Posted Date
- 2018-11-26
- Lead Sponsor
- Pharmbio Korea Co., Ltd.
- Target Recruit Count
- 235
- Registration Number
- NCT03509220
- Locations
- 🇰🇷
Chonnam National University Hospital, Gwangju, Korea, Republic of
🇰🇷Kangbuk Samsung Hospital, Seoul, Korea, Republic of
🇰🇷Korea University Guro Hospital, Seoul, Korea, Republic of
Effect of Probiotic Lactobacilli (Lacidofil Cap®) for the Prevention of Antibiotic-Associated Diarrhea
Completed
- Conditions
- Antibiotics Associated ColitisPulmonary Infection
- First Posted Date
- 2010-01-28
- Last Posted Date
- 2010-04-20
- Lead Sponsor
- Pharmbio Korea Co., Ltd.
- Target Recruit Count
- 214
- Registration Number
- NCT01058356
- Locations
- 🇰🇷
KASID IBD Research Group, Seoul, Korea, Republic of
© Copyright 2025. All Rights Reserved by MedPath